Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05984719 · ClinicalTrials.gov registry record
New Daily Persistent Headache Survey
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 803
- Enrollment target
NCT05984719: Completed study, sponsored by The University of Texas Health Science Center, Houston.
NCT05984719 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 803 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05984719 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 803 participants
- Enrollment target
Study Summary
Purpose: to explore headache characteristics and treatment effects of patient with new daily persistent headache (NDPH) through an online survey. Research design: Online survey of patients with new daily persistent headache. Risks: Risks include a breach of confidentiality as well as fatigue from taking the survey online. Importance of knowledge that may recently be expected to result: The study aims to discover new information in a very understudied disease. This information could, in future studies, help change the diagnostic criteria or lead to new treatment options.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 803 participants |
| Start Date | 2023-06-19 |
| Est. Completion | 2024-01-31 |
What the finished NCT05984719 record still lists
NCT05984719 is an observational study that tracks outcomes without assigning an intervention. The registered 803 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05984719 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05984719 about?
NCT05984719 is a clinical study titled "New Daily Persistent Headache Survey". Purpose: to explore headache characteristics and treatment effects of patient with new daily persistent headache (NDPH) through an online survey. Research design: Online survey of patients with new daily persistent headache. Risks: Risks include a breach of confidentiality as well as fatigue from ...
What is the current status of trial NCT05984719?
This trial is currently completed. The enrollment target is 803 participants. The study started on 2023-06-19. Estimated completion is 2024-01-31.
Who is sponsoring clinical trial NCT05984719?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04423211 · 804 participants · Phase 3
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- NCT06522022 · 804 participants · NA
PTSD Screening in Pregnant Black Women
- NCT03524430 · 801 participants · NA
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy
- NCT04613596 · 806 participants · Phase 2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI